[1]
Fu , P. et al. 2026. Metabolic-Epigenetic Reprogramming in Cancer: Cell-State Plasticity, Tumor Microenvironment, and Therapeutic Opportunities. Cancer Biome and Targeted Therapy . 1, 4 (Nov. 2026), 252–278. DOI:https://doi.org/10.66505/cbtt.v1i4.56.